SightfileU.S. market data from official filings

CELCUITY INC (CELC)

Name: CELCUITY INC (CELC) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001603454 · EDGAR filings · Updated 2026-07-16

CELCUITY INC (CELC) has reported institutional ownership of 101.5%, with 276 institutional managers holding positions valued at $5.58B per the latest 13F reporting period.

Institutional ownership

101.5%

Institutional managers

276

Reported 13F value

$5.58B

Insider activity

33 trans.

$49.9K net buying

Latest updates

2026-07-16 — SCHEDULE 13G filed
2026-07-16 — SCHEDULE 13D/A filed
2026-07-16 — Insider transaction reported (Form 4)
2026-07-15 — Amended current report (8-K/A) filed
2026-07-15 — Current report (8-K) filed
2026-07-14 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CELCUITY INC has 276 institutional holders and institutional ownership of 101.5%.

Insider activity

Insiders reported 33 transactions (4 buys, 13 sells) across 8 reporting insiders, with a net reported value of $49.9K.

Related companies

CENTESSA PHARMACEUTICALS PLC (CNTA) · XENON PHARMACEUTICALS INC (XENE) · TELEFLEX INCORPORATED (TFX) · MSA SAFETY INC (MSA) · BIO RAD LABS INC (BIO) · LANTHEUS HLDGS INC (LNTH)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-16.